UPDATE : Monday, September 7, 2020
상단여백
Ministry revokes Kolon Life Science’s innovative drug company status by Lee Han-soo 2019-11-15 17:26
AbbVie presents new data for ankylosing spondylitis treatment in US by Lee Han-soo 2019-11-15 11:40
Merck Korea wins award for helping families with infertility problems by Lee Han-soo 2019-11-14 18:05
Prosecutors raid drugmakers, distributors for suspected bid-rigging by Jeong Sae-im 2019-11-14 15:27
‘Novartis’ Kymriah takes one step closer to cancer cure’ by Lee Han-soo 2019-11-14 13:24
라인
iCure to apply for testing incrementally modified cancer drugs in US by Lee Han-soo 2019-11-13 17:35
JW Pharmaceutical launches joint-stock company in Vietnam by Lee Han-soo 2019-11-13 16:52
‘Generic drugs must indicate ingredient names on label’ by Kim Yun-mi 2019-11-13 15:51
Daewoong releases trial results for autoimmune disease treatment in US by Lee Han-soo 2019-11-12 14:09
Hanmi to get ₩11.6 billion in royalty if FDA approves Rolontis by Lee Han-soo 2019-11-11 18:02
라인
Genexine’s new immunotherapy shows stability even in high dose by Jeong Sae-im 2019-11-11 13:36
Medpacto releases trial results at US conference by Lee Han-soo 2019-11-11 13:27
Yuhan, Cyclica to co-develop new drugs by Lee Han-soo 2019-11-07 18:01
Takeda’s labor turmoil goes to extremes amid rumored unit sell-off by Kim Yun-mi 2019-11-07 16:10
‘One-third of heart attack survivors overlook risk of recurrence’ by Lee Han-soo 2019-11-06 16:34
라인
AbbVie’s hepatitis C drug gets 8-week therapy regardless of cirrhosis by Kim Yun-mi 2019-11-06 16:00
Crystal Genomics, Daehwa win patent for patch-form arthritis drug by Lee Han-soo 2019-11-06 15:57
Dong-A ST's treatment of nail athlete's foot dominates local market by Lee Han-soo 2019-11-06 14:09
Regulator to consider re-classifying choline alfoscerate as functional food by Kim Yun-mi 2019-11-06 13:54
Daewoong to sell Merck's cardiovascular disease treatment by Lee Han-soo 2019-11-05 15:05
여백
여백
여백
Back to Top